CNTX
Context Therapeutics Inc
NASDAQ: CNTX · HEALTHCARE · BIOTECHNOLOGY
$2.34
-6.77% today
Updated 2026-04-29
Market cap
$207.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $4
Volume
0.9M
Context Therapeutics Inc (CNTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $24.01M | $68.34M | $273548.00 | $467340.00 | $51.31M | $37.97M | $16.06M | $98.13M |
| Cash & equivalents | $16.23M | $60.68M | $226603.00 | $341037.00 | $49.64M | $35.50M | $14.45M | $94.43M |
| Current assets | $17.06M | $61.34M | $239607.00 | $349709.00 | $51.26M | $37.85M | $16.05M | $97.90M |
| Total liabilities | $10.89M | $9.38M | $24.23M | $17.39M | $3.03M | $3.21M | $4.19M | $2.86M |
| Current liabilities | $4.91M | $4.97M | $24.11M | $9.55M | $3.03M | $3.21M | $4.19M | $2.75M |
| Long-term debt | $1.96M | $390000.00 | — | $69040.00 | — | — | — | — |
| Shareholder equity | $13.12M | $58.95M | $-23.96M | $-16.92M | $48.27M | $34.76M | $11.87M | $95.27M |
| Retained earnings | $-72.81M | $-97.55M | $-25.44M | $-18.80M | $-29.25M | $-44.09M | $-68.05M | $-94.78M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | $1.40M | $1.40M | — | — | — | — | — | — |